Estrogen replacement therapy : A survey of older women's attitudes.
To understand the low prevalence of estrogen use among older women.
To examine the reasons for the use and nonuse of estrogen replacement therapy.
Subjects and Methods
Nonblack women (n=7667), aged 65 years or older, who participated in the Multi-center Study of Osteoporotic Fractures completed an estrogen questionnaire.
Of the subjects, 1335 (17.4%) were currently using oral estrogens, 2084 (27.2%) were past users, and 4248 (55.4%) had never used oral estrogen therapy.
The self-reported primary reasons for current users to have initiated therapy included hysterectomy (43.5%), menopausal symptoms (39.3%), prescribed by a physician (38.7%), or prevention or treatment of osteoporosis (33.6%). Of the 2084 former estrogen users (27.2%), the main reasons for starting therapy included prescribed by a physician (44.7%), menopausal symptoms (49.2%), and hysterectomy (28.5%). Approximately 30% of past estrogen users reported the primary reason for discontinuing therapy as « feeling that they didn't need it, » whereas 16.4% reported undesirable side effects with bleeding as the most common (45.0%). The main reason women never started estrogen therapy (55.4%) was they feared that the medication was harmful (38.1%) or they felt they did not need it (29.5%). (...)
Mots-clés Pascal : Oestrogène, Chimiothérapie, Traitement substitutif, Ménopause, Ostéoporose, Cardiopathie, Epidémiologie, Voie orale, Traitement, Vieillard, Homme, Femelle, Voie percutanée, Indication, Observance médicamenteuse, Californie, Etats Unis, Amérique du Nord, Amérique, Système ostéoarticulaire pathologie, Ostéopathie, Appareil circulatoire pathologie
Mots-clés Pascal anglais : Estrogen, Chemotherapy, Replacement therapy, Menopause, Osteoporosis, Heart disease, Epidemiology, Oral administration, Treatment, Elderly, Human, Female, Percutaneous route, Indication, Drug compliance, California, United States, North America, America, Diseases of the osteoarticular system, Bone disease, Cardiovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0334015
Code Inist : 002B02O. Création : 10/04/1997.